Ticker
ARVNCompany Name
ARVINAS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Capital Expenditure | Capital Expenditures Coverage | Net Cash Flow - Operations |
---|---|---|---|
6/30/2025 | $ 2.6M | 0 | $ -396.4M |
3/31/2025 | $ 2M | 0 | $ -250.7M |
12/31/2024 | $ 1.7M | 0 | $ -259.3M |
9/30/2024 | $ 1.5M | 0 | $ -258.3M |
6/30/2024 | $ 1.9M | 0 | $ -215.1M |
3/31/2024 | $ 1.9M | 0 | $ -354.1M |
12/31/2023 | $ 2.9M | 0 | $ -347.8M |
9/30/2023 | $ 3.9M | 0 | $ -335.9M |
6/30/2023 | $ 5M | 0 | $ -317.7M |
3/31/2023 | $ 5.8M | 0 | $ -307.6M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / CapEx
(=) CapEx Coverage
CapEx Coverage for ARVINAS INC is calculated as follows: CF - Operations [ $ -76.91M ] / CapEx [ $ 6.38M ]
(=) CapEx Coverage [ 0 ]
Minimum
Jun 30, 2022
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 2.21K |
---|---|
min | 0.01 |
max | 17.91 |
average | 4.42 |
median | 3.01 |
std | 4.02 |